June 11, 2007
"Patents, Exclusivity, and Generic Drugs" at the Food and Drug Law Institute
This event has already occurred.
Related Services
Related Insights
Paul Debolt and Christopher Griesedieck Publish “Court allows 1 'constructive' change theory against prime contractor, dismisses another” in Westlaw Today
Paul Debolt and Christopher Griesedieck Publish “Court allows 1 'constructive' change theory against prime contractor, dismisses another” in Westlaw Today
November 21, 2023
1min
Medical Device Update: FDA Publishes Three New Guidance Documents for the 510(k) Premarket Notification Program
Medical Device Update: FDA Publishes Three New Guidance Documents for the 510(k) Premarket Notification Program
October 06, 2023
6min
Senate HELP Committee Requests Comments on Discussion of Draft Legislation to Reauthorize the Pandemic and All-Hazards Preparedness Act, Including an Extension and Expansion of the Material Threat Medical Countermeasure Priority Review Program
Senate HELP Committee Requests Comments on Discussion of Draft Legislation to Reauthorize the Pandemic and All-Hazards Preparedness Act, Including an Extension and Expansion of the Material Threat Medical Countermeasure Priority Review Program
July 06, 2023
3min
Events
Developments in Pharmaceutical and Biotech Patent Law 2023
Developments in Pharmaceutical and Biotech Patent Law 2023
December 01, 2023 New York, NY - Practising Law Institute